UA42715C2 - Полінуклеотидна вакцина на основі плазмідної днк, імуногенна композиція(варіанти) - Google Patents
Полінуклеотидна вакцина на основі плазмідної днк, імуногенна композиція(варіанти)Info
- Publication number
- UA42715C2 UA42715C2 UA95094152A UA95094152A UA42715C2 UA 42715 C2 UA42715 C2 UA 42715C2 UA 95094152 A UA95094152 A UA 95094152A UA 95094152 A UA95094152 A UA 95094152A UA 42715 C2 UA42715 C2 UA 42715C2
- Authority
- UA
- Ukraine
- Prior art keywords
- plasmid dna
- variants
- polynucleotide vaccine
- immunogenic composition
- terminator
- Prior art date
Links
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 title abstract 2
- 239000013612 plasmid Substances 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title 1
- 230000035897 transcription Effects 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 108010006025 bovine growth hormone Proteins 0.000 abstract 1
- 229940065638 intron a Drugs 0.000 abstract 1
- 229930027917 kanamycin Natural products 0.000 abstract 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 abstract 1
- 229960000318 kanamycin Drugs 0.000 abstract 1
- 229930182823 kanamycin A Natural products 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Полінуклеотидна вакцина на основі плазмідної ДНК містить регуляторну послідовність, яка являє собою промотор цитомегаловірусу з послідовністю інтрону А (1,63 т.п.н.), термінатор транскрипції, що являє собою термінатор транскрипції бичачого гормону росту (0,55 т.п.н.), бактеріальну область початку реплікації, що являє собою ori (0,64 т.п.н.) та маркер, що визначається, що являє собою ген стійкості до канаміцину (1,30 т.п.н.).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3238393A | 1993-03-18 | 1993-03-18 | |
| US8998593A | 1993-07-08 | 1993-07-08 | |
| PCT/US1994/002751 WO1994021797A1 (en) | 1993-03-18 | 1994-03-14 | Nucleic acid pharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA42715C2 true UA42715C2 (uk) | 2001-11-15 |
Family
ID=26708344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA95094152A UA42715C2 (uk) | 1993-03-18 | 1994-03-14 | Полінуклеотидна вакцина на основі плазмідної днк, імуногенна композиція(варіанти) |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0620277A1 (uk) |
| JP (2) | JP2812352B2 (uk) |
| CN (1) | CN1119458A (uk) |
| AU (1) | AU676258B2 (uk) |
| BG (1) | BG63126B1 (uk) |
| BR (1) | BR9406007A (uk) |
| CA (1) | CA2119175A1 (uk) |
| CZ (1) | CZ290315B6 (uk) |
| DZ (1) | DZ1759A1 (uk) |
| FI (1) | FI954329A (uk) |
| HR (1) | HRP940175A2 (uk) |
| HU (1) | HUT73397A (uk) |
| IL (1) | IL108915A0 (uk) |
| NO (1) | NO953649L (uk) |
| NZ (1) | NZ263680A (uk) |
| PL (1) | PL178626B1 (uk) |
| RO (1) | RO117710B1 (uk) |
| SI (1) | SI9420014A (uk) |
| SK (1) | SK114295A3 (uk) |
| UA (1) | UA42715C2 (uk) |
| WO (1) | WO1994021797A1 (uk) |
| YU (1) | YU12894A (uk) |
Families Citing this family (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849719A (en) * | 1993-08-26 | 1998-12-15 | The Regents Of The University Of California | Method for treating allergic lung disease |
| US6911216B1 (en) | 1994-10-12 | 2005-06-28 | Genzyme Corporation | Targeted delivery via biodegradable polymers |
| US5736524A (en) | 1994-11-14 | 1998-04-07 | Merck & Co.,. Inc. | Polynucleotide tuberculosis vaccine |
| DE19512142A1 (de) * | 1995-03-31 | 1996-10-02 | Immuno Ag | Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält |
| US6083925A (en) * | 1995-06-07 | 2000-07-04 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
| US6017897A (en) * | 1995-06-07 | 2000-01-25 | Pasteur Merieux Connaught Canada | Nucleic acid respiratory syncytial virus vaccines |
| US6019980A (en) | 1995-06-07 | 2000-02-01 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
| US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
| FR2751225B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique aviaire |
| US6204250B1 (en) | 1996-11-22 | 2001-03-20 | The Mount Sinai Medical Center Of The City Of New York | Immunization of infants |
| ATE284613T1 (de) * | 1997-02-14 | 2005-01-15 | Merck & Co Inc | Polynukleotid-impfstoff-formulierungen |
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| US6686339B1 (en) | 1998-08-20 | 2004-02-03 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| EP1105490A1 (en) | 1998-08-20 | 2001-06-13 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein c of chlamydia |
| US6693087B1 (en) | 1998-08-20 | 2004-02-17 | Aventis Pasteur Limited | Nucleic acid molecules encoding POMP91A protein of Chlamydia |
| US6881723B1 (en) | 1998-11-05 | 2005-04-19 | Powderject Vaccines, Inc. | Nucleic acid constructs |
| US7618797B2 (en) | 1998-12-22 | 2009-11-17 | Pfizer Inc | Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| US7691389B2 (en) | 1998-12-22 | 2010-04-06 | Pfizer Inc | Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| WO2000047227A2 (en) | 1999-02-09 | 2000-08-17 | Powderject Vaccines, Inc. | Mycobacterium tuberculosis, immunization |
| US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| JP2001151698A (ja) * | 1999-09-10 | 2001-06-05 | Nichiko Pharmaceutical Co Ltd | インフルエンザワクチン |
| CA2721011A1 (en) | 1999-10-22 | 2001-05-03 | Aventis Pasteur Limited | Modified gp100 and uses thereof |
| US7196066B1 (en) | 1999-11-03 | 2007-03-27 | Powderject Vaccines, Inc. | DNA-vaccines based on constructs derived from the genomes of human and animal pathogens |
| US6852705B2 (en) | 2000-01-21 | 2005-02-08 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| US7078388B2 (en) | 2000-01-21 | 2006-07-18 | Merial | DNA vaccines for farm animals, in particular bovines and porcines |
| EP1792995A3 (en) | 2000-05-08 | 2007-06-13 | Sanofi Pasteur Limited | Chlamydia secretory locus orf and uses thereof |
| WO2001085932A2 (en) | 2000-05-10 | 2001-11-15 | Aventis Pasteur Limited | Immunogenic polypeptides encoded by mage minigenes and uses thereof |
| US20060024670A1 (en) | 2004-05-18 | 2006-02-02 | Luke Catherine J | Influenza virus vaccine composition and methods of use |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| EP2152871A4 (en) * | 2007-05-31 | 2011-01-05 | Becton Dickinson Co | SEQUENCES AND METHOD FOR DETECTING INFLUENZA VIRUS A AND INFLUENZA VIRUS B |
| US8354230B2 (en) * | 2007-12-21 | 2013-01-15 | Quest Diagnostics Investments Inc. | Multiplex detection assay for influenza and RSV viruses |
| WO2010012045A1 (en) | 2008-08-01 | 2010-02-04 | Gamma Vaccines Pty Limited | Influenza vaccines |
| US8894997B2 (en) | 2009-04-30 | 2014-11-25 | Vanderbilt University | Monoclonal antibodies to influenza H1N1 virus uses thereof |
| SG168423A1 (en) * | 2009-07-13 | 2011-02-28 | Agency Science Tech & Res | Influenza detection method and kit therefor |
| AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
| AR083533A1 (es) | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
| AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
| WO2013033092A2 (en) | 2011-09-03 | 2013-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Streptococcus suis pilus antigens |
| US10383835B2 (en) | 2012-03-14 | 2019-08-20 | The Regents Of The University Of California | Treatment of inflammatory disorders in non-human mammals |
| ES2689878T3 (es) | 2013-02-21 | 2018-11-16 | Boehringer Ingelheim Vetmedica Gmbh | Proteínas H5 del virus de la gripe H5N1 para su uso como un medicamento |
| WO2014147087A1 (en) * | 2013-03-18 | 2014-09-25 | Imaxio | Influenza nucleoprotein vaccines |
| MX2016003855A (es) | 2013-09-25 | 2016-08-04 | Zoetis Services Llc | Composicion de vacuna de circovirus porcino tipo 2b divergente y procedimientos de uso. |
| AU2015241107B2 (en) | 2014-04-03 | 2019-10-03 | Boehringer Ingelheim Animal Health USA Inc. | Porcine epidemic diarrhea virus vaccine |
| US9920302B2 (en) | 2015-08-31 | 2018-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Pestivirus vaccines for congenital tremors |
| AU2016323106A1 (en) | 2015-09-16 | 2018-03-29 | Boehringer Ingelheim Animal Health USA Inc. | Salmonella Choleraesuis-Salmonella Typhimurium vaccines |
| CN109790550B (zh) | 2016-09-20 | 2024-02-09 | 勃林格殷格翰动物保健有限公司 | 新颖的启动子 |
| UY37405A (es) | 2016-09-20 | 2018-03-23 | Boehringer Ingelheim Vetmedica Gmbh | Vectores de adenovirus canino |
| WO2018054822A1 (en) | 2016-09-20 | 2018-03-29 | Boehringer Ingelheim Vetmedica Gmbh | New swine influenza vaccine |
| AU2017329669A1 (en) | 2016-09-20 | 2019-03-21 | Boehringer Ingelheim Vetmedica Gmbh | New EHV insertion site ORF70 |
| PL3534939T3 (pl) | 2016-11-03 | 2023-06-12 | Boehringer Ingelheim Vetmedica Gmbh | Szczepionka przeciw parwowirusowi świń i wirusowi zespołu rozrodczo-oddechowego świń oraz sposoby ich wytwarzania |
| KR20240090735A (ko) | 2016-11-03 | 2024-06-21 | 베링거잉겔하임베트메디카게엠베하 | 돼지 파보바이러스에 대한 백신 |
| AU2018212843A1 (en) | 2017-01-30 | 2019-06-27 | Boehringer Ingelheim Animal Health USA Inc. | Porcine coronavirus vaccines |
| CN110869047A (zh) | 2017-07-12 | 2020-03-06 | 勃林格殷格翰动物保健美国有限公司 | 塞内卡病毒a免疫原性组合物及其方法 |
| EP3675903A1 (en) | 2017-09-23 | 2020-07-08 | Boehringer Ingelheim Vetmedica GmbH | Paramyxoviridae expression system |
| WO2019092027A1 (en) | 2017-11-09 | 2019-05-16 | Boehringer Ingelheim Vetmedica Gmbh | Sapelovirus immunogenic compositions and uses thereof |
| CN111712575B (zh) | 2018-02-23 | 2024-07-19 | 勃林格殷格翰动物保健有限公司 | 表达外源猫副粘病毒基因的重组病毒载体系统及由其制备的疫苗 |
| EA202092164A1 (ru) | 2018-03-19 | 2021-02-10 | Бёрингер Ингельхайм Ветмедика Гмбх | Новый ehv с инактивированным ul18 и/или ul8 |
| JP7245260B2 (ja) | 2018-03-19 | 2023-03-23 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | Ｅｈｖ挿入部位ｕｌ４３ |
| US11957746B2 (en) | 2018-03-26 | 2024-04-16 | Boehringer Ingelheim Animal Health USA Inc. | Method of producing an immunogenic composition |
| JP7284822B2 (ja) | 2018-09-20 | 2023-05-31 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 改変ｐｅｄｖスパイクタンパク質 |
| US10905758B2 (en) | 2018-09-20 | 2021-02-02 | Boehringer Ingelheim Vetmedica Gmbh | Intranasal vector vaccine against porcine epidemic diarrhea |
| IT201900007060A1 (it) | 2019-05-21 | 2020-11-21 | St Superiore Di Sanita | Cellule tumorali ingegnerizzate e loro usi |
| IT201900012540A1 (it) | 2019-07-22 | 2021-01-22 | Humanitas Mirasole Spa | Inibitori di CHI3L1 e loro usi |
| JP2023513135A (ja) | 2020-02-06 | 2023-03-30 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 抗ラブドウイルス抗体を検出するのに有用なポリペプチド |
| AU2021356630A1 (en) | 2020-10-05 | 2023-06-08 | Boehringer Ingelheim Vetmedica Gmbh | Fusion protein useful for vaccination against rotavirus |
| JP2023544403A (ja) | 2020-10-05 | 2023-10-23 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | サーコウイルス科カプシドタンパク質を含む融合タンパク質、及びそれから構成されるキメラウイルス様粒子 |
| US20240050555A1 (en) | 2022-04-05 | 2024-02-15 | Boehringer Ingelheim Vetmedica Gmbh | Immunogenic composition useful for vaccination against rotavirus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86354A0 (en) * | 1987-05-22 | 1988-11-15 | Orion Yhtymae Oy | Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof |
| DE69034078T2 (de) * | 1989-03-21 | 2004-04-01 | Vical, Inc., San Diego | Expression von exogenen Polynukleotidsequenzen in Wirbeltieren |
| US5643578A (en) * | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
-
1994
- 1994-03-09 IL IL10891594A patent/IL108915A0/xx unknown
- 1994-03-09 EP EP94200605A patent/EP0620277A1/en not_active Withdrawn
- 1994-03-14 BR BR9406007A patent/BR9406007A/pt not_active Application Discontinuation
- 1994-03-14 RO RO95-01622A patent/RO117710B1/ro unknown
- 1994-03-14 UA UA95094152A patent/UA42715C2/uk unknown
- 1994-03-14 PL PL94310677A patent/PL178626B1/pl unknown
- 1994-03-14 CZ CZ19952373A patent/CZ290315B6/cs not_active IP Right Cessation
- 1994-03-14 CN CN94191485A patent/CN1119458A/zh active Pending
- 1994-03-14 WO PCT/US1994/002751 patent/WO1994021797A1/en active IP Right Grant
- 1994-03-14 HU HU9502702A patent/HUT73397A/hu unknown
- 1994-03-14 SK SK1142-95A patent/SK114295A3/sk unknown
- 1994-03-14 NZ NZ263680A patent/NZ263680A/en unknown
- 1994-03-14 SI SI9420014A patent/SI9420014A/sl not_active IP Right Cessation
- 1994-03-16 DZ DZ940021A patent/DZ1759A1/fr active
- 1994-03-16 CA CA002119175A patent/CA2119175A1/en not_active Abandoned
- 1994-03-17 AU AU57889/94A patent/AU676258B2/en not_active Ceased
- 1994-03-17 YU YU12894A patent/YU12894A/sh unknown
- 1994-03-17 HR HR08/089,985A patent/HRP940175A2/xx not_active Application Discontinuation
- 1994-03-18 JP JP6049102A patent/JP2812352B2/ja not_active Expired - Fee Related
-
1995
- 1995-09-14 FI FI954329A patent/FI954329A/fi unknown
- 1995-09-15 NO NO953649A patent/NO953649L/no not_active Application Discontinuation
- 1995-09-18 BG BG100006A patent/BG63126B1/bg unknown
-
1997
- 1997-10-22 JP JP29013797A patent/JP3608642B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3608642B2 (ja) | 2005-01-12 |
| YU12894A (sh) | 1997-12-05 |
| HRP940175A2 (en) | 1997-04-30 |
| FI954329A0 (fi) | 1995-09-14 |
| SK114295A3 (en) | 1996-02-07 |
| PL310677A1 (en) | 1995-12-27 |
| HU9502702D0 (en) | 1995-11-28 |
| HUT73397A (en) | 1996-07-29 |
| WO1994021797A1 (en) | 1994-09-29 |
| BG63126B1 (bg) | 2001-04-30 |
| JPH10113194A (ja) | 1998-05-06 |
| FI954329A (fi) | 1995-09-14 |
| BG100006A (bg) | 1996-12-31 |
| SI9420014A (en) | 1996-08-31 |
| AU5788994A (en) | 1994-09-22 |
| NZ263680A (en) | 1997-05-26 |
| AU676258B2 (en) | 1997-03-06 |
| CN1119458A (zh) | 1996-03-27 |
| NO953649D0 (no) | 1995-09-15 |
| EP0620277A1 (en) | 1994-10-19 |
| JPH0795888A (ja) | 1995-04-11 |
| IL108915A0 (en) | 1994-06-24 |
| CZ237395A3 (en) | 1996-02-14 |
| JP2812352B2 (ja) | 1998-10-22 |
| PL178626B1 (pl) | 2000-05-31 |
| BR9406007A (pt) | 1996-01-02 |
| NO953649L (no) | 1995-11-17 |
| DZ1759A1 (fr) | 2002-02-17 |
| RO117710B1 (ro) | 2002-06-28 |
| CA2119175A1 (en) | 1994-09-19 |
| CZ290315B6 (cs) | 2002-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA42715C2 (uk) | Полінуклеотидна вакцина на основі плазмідної днк, імуногенна композиція(варіанти) | |
| DE3276241D1 (en) | Expression of polypeptides in yeast | |
| DE3279030D1 (en) | Novel vector plasmids | |
| EP0249676A3 (en) | Method for the expression of genes in plants | |
| AU6893587A (en) | Recombinant dna sequences, vectors containing them and method for the use thereof | |
| DE2862496D1 (en) | Method for polypeptide production involving expression of a heterologous gene, recombinant microbial cloning vehicle containing said gene and bacterial culture transformed by said cloning vehicle | |
| AU604743B2 (en) | Phosphinothricin-resistance gene, and its use | |
| UA13380A (uk) | Спосіб одержаhhя лейкоцитарhого іhтерфероhу | |
| GB9118759D0 (en) | Recombinant dna | |
| CA2072007A1 (en) | Cloning Vector for Use in Lactic Acid Bacteria and a Method for Constructing the Same | |
| IE843270L (en) | Methionine-prochymosin plasmid. | |
| DE3277631D1 (en) | Recombinant plasmid and microorganism containing same | |
| EP0316677A3 (en) | Method for cloning in lactic acid bacteria | |
| KR910001046A (ko) | 비융합 단백질을 제조하기 위한 미생물내 발현용 발현벡터 | |
| DE3380878D1 (en) | Method of heterologous cloning of gene in bacillus microorganism | |
| ES8306176A1 (es) | Procedimiento para la preparacion de un vector hibrido y la clonacion de adn-ajeno en organismos hospetantes. | |
| EP0068647A3 (en) | Plasmids, plasmid hosts, and their preparation | |
| DE3570694D1 (en) | Recombinant saccharomyces | |
| JPS5756495A (en) | Novel dna-introduction vector and recombinant dna | |
| EP0245218A3 (en) | A plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone | |
| GB2067574B (en) | Microbiologically prepared polypeptide with the amino acid sequence of proinsulin of a primate dna and plasmids which code for this sequence microorganisms which contain this genetic information and processes for their preparation | |
| WO1993018151A1 (fr) | Element transposable originaire d'une bacterie du genre brevibacterium | |
| HK192795A (en) | A novel system of inducible positive regulation of use for production of heterologous proteins | |
| EP0248207A3 (en) | Gene for gentamycin resistance and its use as a marker | |
| EP0038156A3 (en) | A plasmid and its microbiological preparation |